AB
Arcutis Biotherapeutics Inc
🇺🇸XNAS.ARQTUnited StatesHealthcare
$23.57USDdown -0.70 (-2.88%)OpenEnd of day5:08 PM
Price$23.57-0.70 (-2.88%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03969K1088
- CUSIP
- 03969K108
Company
- Employees
- 354
- Headquarters
- Westlake Village, United States
- Website
- https://www.arcutis.com
- CEO
- Mr. Todd Franklin Watanabe M.A.
Market
- Shares outstanding
- 125.7M
- Market cap
- $2.96B
Key dates
- Next earnings
- Oct 27, 2026
Highlights
- Market cap
- $2.96B
- EPS LTM
- $0.21
- P/E LTM
- 124.94
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $463.98M+76.11%up year on year
- Net income
- $28.52M+130.58%up year on year
- Gross margin
- 91.14%+2.3%up year on year
- Free cash flow
- $39.15M+154.89%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.